XERIS BIOPHARMA HOLDINGS, INC.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-80.6M | $-80.9M | $377.0K | $8.3M |
| FY2021 | $-95.5M | $-96.6M | $1.1M | $11.4M |
| FY2022 | $-102.9M | $-102.9M | — | $12.2M |
| FY2023 | $-47.0M | $-47.0M | — | $10.7M |
| FY2024 | $-37.0M | $-37.0M | — | $18.4M |
| FY2025 | $28.6M | $28.6M | — | $22.4M |